Arena Pharmaceuticals to Release Third Quarter 2020 Financial Results and Provide Corporate Update on November 9
Conference Call & Webcast Information
Dial-in: (877) 643-7155 (
Conference ID: 6166976
Please join the conference call at least 20 minutes early to register. You can access the live webcast under the investor relations section of Arena's website. A replay of the event will be archived for 30 days after the call.
In a rapidly changing global market, we work with a sense of urgency every day to understand the needs of all our stakeholders, identify bold, sometimes disruptive, ideas to get our medicines to patients, and relentlessly execute until it's done.
ARENA - Care More. Act Differently.
Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about Arena's position, drive, portfolio, prioritization, financial position, team, and building of the company. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include those disclosed in Arena's filings with the
Vice President, Investor Relations & Corporate Communications
Director, Investor Relations
View original content to download multimedia:http://www.prnewswire.com/news-releases/arena-pharmaceuticals-to-release-third-quarter-2020-financial-results-and-provide-corporate-update-on-november-9-301164378.html